{"id":16560,"date":"2021-01-05T01:25:15","date_gmt":"2021-01-04T22:25:15","guid":{"rendered":"https:\/\/www.klimikdergisi.org\/\/2021\/01\/05\/seroprevalence-of-hepatitis-b-virus-hepatitis-c-virus-human-immunodeficiency-virus-infections-and-syphilis-in-blood-donors\/"},"modified":"2021-01-05T01:25:15","modified_gmt":"2021-01-04T22:25:15","slug":"seroprevalence-of-hepatitis-b-virus-hepatitis-c-virus-human-immunodeficiency-virus-infections-and-syphilis-in-blood-donors","status":"publish","type":"post","link":"https:\/\/www.klimikdergisi.org\/en\/2021\/01\/05\/seroprevalence-of-hepatitis-b-virus-hepatitis-c-virus-human-immunodeficiency-virus-infections-and-syphilis-in-blood-donors\/","title":{"rendered":"Seroprevalence of Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus Infections and Syphilis in Blood Donors"},"content":{"rendered":"<h1>Abstract<\/h1>\n<p> <strong>Objective<\/strong>: The objective is to obtain the seroprevalence of HBsAg, anti-HCV, anti-HIV, RPR and to assess their rates according to time, gender, age and other specifications in blood donors.<\/p>\n<p> <strong>Methods<\/strong>: HBsAg, anti-HCV, anti-HIV and RPR results of 16 362 blood donors from January 1, 2005 to December 31, 2009 have been evaluated retrospectively. Prevalence of HBsAg, anti-HCV, anti-HIV, and RPR were investigated according to gender, age and other specifications of the donor.\u00a0<\/p>\n<p> <strong>Results<\/strong>: 15,479 (94.6%) of the 16,362 donors were male and 883 (5.4%) were female. The age range of the donors was between 18 and 64 years, and the mean age was 31.55\u00b18.94. 611 (3.73%) of the donors were repeat donors and 15,751 (96.27%) were the relatives of patients. HBsAg was positive in 85 (0.52%), anti-HCV in 59 (0.36%), anti-HIV in 16 (0.1%) and RPR in 13 (0.08%) of the donors. Western Blot confirmation test was reported positive in one of the 16 anti-HIV-positive donors. HBsAg positivity was 0.79% in 2005 and it \u00a0regressed to 0.37% in 2009 (p=0.024).\u00a0<\/p>\n<p> <strong>Conclusions<\/strong>: Seropositivity rate of HBsAg was lower than that of Turkey in general and seroprevalence of HBsAg decreased over years.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract Objective: The objective is to obtain the seroprevalence of HBsAg, anti-HCV, anti-HIV, RPR and to assess their rates according to time, gender, age and other specifications in blood donors. Methods: HBsAg, anti-HCV, anti-HIV and RPR results of 16 362 blood donors from January 1, 2005 to December 31, 2009 have been evaluated retrospectively. Prevalence [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5130],"tags":[3227,4033,4035,4037,4039],"class_list":["post-16560","post","type-post","status-publish","format-standard","hentry","category-original-article","tag-blood-donors","tag-hepatitis-b-surface-antigens","tag-hepatitis-c-antibodies","tag-hiv-seropositivity","tag-syphilis-serodiagnosis"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/16560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/comments?post=16560"}],"version-history":[{"count":0,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/posts\/16560\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/media?parent=16560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/categories?post=16560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimikdergisi.org\/en\/wp-json\/wp\/v2\/tags?post=16560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}